NCT06469528View on ClinicalTrials.gov

ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

October 5, 2025

Study Completion Date

October 5, 2026

Conditions

Coronary Artery Disease

Interventions

DRUG

Colchicine 0.5 MG

Low dose daily colchicine

All Listed Sponsors

collaborator

King's College London

OTHER

lead

King's College Hospital NHS Trust

OTHER